Gyre Therapeutics
GYRE
GYRE
80 hedge funds and large institutions have $90.2M invested in Gyre Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 78 → 80 (+2)
0.11% more ownership
Funds ownership: 8.52% → 8.63% (+0.11%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
80
Holding in Top 10
2
Calls
$398K
Puts
$76K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$939K | |
| 3 | +$897K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$606K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$604K |
Top Sellers
| 1 | -$3.64M | |
| 2 | -$1.68M | |
| 3 | -$1.3M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$886K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$670K |